Diabetes foot registry study in Africa
Part of Hormones & metabolism clinical trials.
This study collects information from people living in Africa who have diabetes-related foot problems such as ulcers or infections. It aims to understand these conditions better and help improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You live in a participating African country.
- You have diabetes and a foot complication like an ulcer, infection, or gangrene.
- You have had a foot ulcer or amputation in the past because of diabetes.
- You have nerve damage in your feet (peripheral neuropathy) or blood vessel disease in your legs (peripheral arterial disease).
- You are willing to give permission (informed consent) to be in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking for people with diabetes who have an open foot or ankle ulcer. Researchers want to collect samples to find biomarkers, which are natural signs in the body that could help improve treatment and healing. It may be a good fit if you have a diabetic foot ulcer and are not currently in another drug trial for ulcers.
This study creates a registry to collect information about patients with diabetes. It helps doctors better understand the disease and its lab results.
This study tests a new device called Feetsee that helps monitor foot health in people with diabetes. It may help catch foot problems early.
This study looks at why people with diabetes develop foot problems and how these problems affect their lives. It is being done in Jordan and uses a phone survey to collect information.
This trial looks at risk factors other than blood vessel disease that may affect how severe diabetic foot ulcers become. It could help you and your doctor better understand and treat your foot ulcers.
This study collects information about people with diabetes to better understand the condition in everyday life. It may help improve future diabetes care by building a real-world diabetes database.
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.